Chaim Chizic

American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019.

Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ.

Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda.

Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel.

BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

DenX Ltd. is engaged in manufacturing of dental equipment. The firm develops and markets image guided technology for dental training and clinical implementation. The company was founded by Hayka Alon in 1994 and is headquartered in Jerusalem, Israel.

CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel.

Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ.

Zerigo Health, Inc. develops handheld ultra violet device. It offers therapy to psoriasis, eczema, and vitiligo patients. The company was founded by Martyn Gross and Remo Qajar in 2014 and is headquartered in San Diego, CA.

MDRejuvena, Inc. manufactures skin care products. It specializes in providing products that rejuvenate, enhance and maintain skin health for the patients of physicians and skincare professionals worldwide. The company was founded by David F. Hale in 2013 and is headquartered in Carlsbad, CA.

Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel.

Mango DSP Ltd. is engaged in developing and manufacturing of intelligent video solutions providing video encoding appliances and intelligent video analytics. Mango DSP products lead the Intelligent video encoding server market with Multi-channel (1, 2, 4, 8, 16 and 60),Rugged, Embedded, DSP-based, Video Analytic powered appliances as well as Mango’s Video Stabilization & All-in-One License Plate Recognition (LPR) solutions. The company is founded in 1996 and is headquartered in Hid Hasharon, Israel.

Part of HP, Inc., HP Indigo Ltd. is an Israeli company that offers a range of printers for small businesses and enterprises. The company is based in Ness Ziona, Israel. The company's HP LaserJet printers are known for their industry-leading print solutions. In addition, HP Services helps IT simplify, manage, and secure all PC devices across a network, ensuring that businesses run smoothly and employees work at their best. HP also places a strong emphasis on diversity, equity, and inclusion to attract and retain the best employees.

Part of Elbit Systems Ltd., BAE Systems Rokar International Ltd. develops, manufactures, integrates, and supports GPS receivers and guidance systems. The company is based in Jerusalem, Israel. The Israeli company was founded in 1981. Nir Lavi has been the CEO of the company since 2015. BAE Systems Rokar International was acquired by Elbit Systems Ltd. from BAE Systems Plc on April 01, 2021 for $9.30 million.

Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.

D.H.S Medical Ltd. develops a platform technology for treating and monitoring heart failure. Its proprietary technology is designed to measure and monitor real time cardiac motion and based on this information to optimize cardiac performance. The company was founded by Guy Dori and Oscar Lichtenstein in 2010 and is headquartered in Nazareth, Israel.

D Pharm Ltd. provides drug development services.